v3.26.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Operating activities:          
Net income     $ 5,319,000 $ 3,919,000  
Adjustments to reconcile net income from operating activities:          
Provision for credit losses $ 376,000 $ 349,000 556,000 453,000  
Depreciation     423,000 394,000  
Net amortization of securities premiums     19,000 59,000  
Net amortization of loan origination fees (costs)     11,000 (54,000)  
Deferred net loan origination costs     (385,000) (330,000)  
Amortization of intangibles 13,000 17,000 27,000 35,000  
Amortization of investment in low-income housing partnerships 80,000 80,000 161,000 161,000  
Net amortization of purchase fair value adjustments     (16,000) (18,000)  
Net realized loss on sales and calls of available for sale securities     209,000 0  
Change in value of equity securities (220,000) (40,000) (278,000) (12,000)  
Earnings on bank owned life insurance and annuities (71,000) (62,000) (140,000) (119,000)  
Deferred income tax expense     154,000 11,000  
Stock-based compensation expense 42,000 38,000 83,000 75,000  
Gain from life insurance proceeds     0 (20,000)  
Increase in accrued interest receivable and other assets     (589,000) (27,000)  
Increase (decrease) in accrued interest payable and other liabilities     513,000 (1,192,000)  
Net cash provided by operating activities     6,067,000 3,335,000  
Investing activities:          
Securities available for sale     (6,853,000) 0  
Restricted stock     (38,000) 0  
Premises and equipment     (718,000) (188,000)  
Bank owned life insurance     0 (890,000)  
Bank owned life insurance premium and annuity payments     0 (9,000)  
Redemption of equity securities 0 0 0 46,000  
Sales of debt securities available for sale     6,791,000 0  
Maturities of and principal repayments on securities available for sale     9,464,000 2,006,000  
Maturities of and principal repayments on securities held to maturity     6,686,000 6,733,000  
Redemption of restricted stock     0 247,000  
Life insurance claims     0 243,000  
Sale of fixed assets     0 4,000  
Sale of other assets     14,000 0  
Net increase in loans     (34,490,000) (22,063,000)  
Net cash used in investing activities     (19,144,000) (13,871,000)  
Financing activities:          
Net increase in deposits     23,921,000 11,350,000  
Net (decrease) increase in short-term borrowings and securities sold under agreements to repurchase     (6,084,000) 7,478,000  
Repayment of long-term debt     0 (5,000,000)  
Cash dividends     (2,211,000) (2,205,000)  
Purchase of treasury stock     (17,000) (4,000)  
Treasury stock issued for employee stock plans     26,000 30,000  
Net cash provided by financing activities     15,635,000 11,649,000  
Net increase in cash and cash equivalents     2,558,000 1,113,000  
Cash and cash equivalents at beginning of year     11,448,000 10,998,000 $ 10,998,000
Cash and cash equivalents at end of period $ 14,006,000 $ 12,111,000 14,006,000 12,111,000 $ 11,448,000
Supplemental information:          
Interest paid     6,533,000 6,716,000  
Federal income tax paid (no state or foreign taxes paid)     970,000 685,000  
Supplemental schedule of noncash investing and financing activities:          
Transfer of loans to repossessed vehicles     $ 14,000 $ 0